Broad and ERS Genomics both claim victory in latest CRISPR ruling
14-09-2020
Broad Institute presses for CRISPR settlement after EPO revocation
23-01-2020
Vchal / Shutterstock.com
ERS Genomics, the company that provides access to CRISPR/Cas9 IP owned by researcher Emmanuelle Charpentier, has appointed Michael Arciero as vice-president of IP and commercial development.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
ERS Genomics, Michael Arciero, CRISPR, CRISPR/Cas9, intellectual property, USC Stevens Center for Innovation, genetics, technology transfer
